Validity and Usage of the Seasonal Pattern Assessment Questionnaire (SPAQ) in a French Population of Patients with Depression, Bipolar Disorders and Controls.
bipolar disorder
circadian rhythms
psychometry
seasonal affective disorder
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
27 Apr 2021
27 Apr 2021
Historique:
received:
15
03
2021
revised:
21
04
2021
accepted:
22
04
2021
entrez:
30
4
2021
pubmed:
1
5
2021
medline:
1
5
2021
Statut:
epublish
Résumé
The Seasonal Pattern Assessment Questionnaire (SPAQ), by Rosenthal et al. (1984), is by far the most used questionnaire to evaluate seasonal effects on mood and behavior. It includes a general seasonality score (GSS), composed of 6 items, from which cutoffs have been established to screen for seasonal affective disorder (SAD). However, it has never been validated in French and associations with circadian rhythm and symptoms of depression and bipolarity remain unclear. In this study, including 165 subjects (95 controls and 70 patients with depression or bipolar disorder), we confirmed the validity of the French version of the SPAQ, with a two-factor structure (a psychological factor: energy, mood, social activity and sleep length; and a food factor: weight and appetite) and a good fit was observed by all indicators. Mood and social activity dimensions were significantly affected by seasons in the depressed/bipolar group and a stronger global seasonality score (GSS) was associated with more severe phenotypes of depression and mania. Subjects meeting SAD and subsyndromal-SAD criteria also showed a delayed circadian rhythm compared to controls. Simple tools, such as the SPAQ, can aid the identification of significant seasonal changes and have direct implications on therapeutics including the use of bright light therapy in order to enhance personalized treatments, but also to prevent adverse seasonal effects.
Identifiants
pubmed: 33925578
pii: jcm10091897
doi: 10.3390/jcm10091897
pmc: PMC8123881
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Nat Rev Genet. 2008 Oct;9(10):764-75
pubmed: 18802415
Chronobiol Int. 2013 Nov;30(9):1101-7
pubmed: 23931033
Am J Psychiatry. 2006 May;163(5):805-12
pubmed: 16648320
Front Psychiatry. 2019 Mar 01;10:85
pubmed: 30881318
Biol Psychiatry. 1999 Apr 15;45(8):1013-22
pubmed: 10386184
Pharmacol Rev. 2003 Jun;55(2):325-95
pubmed: 12773631
Eur J Neurosci. 2020 Jan;51(1):346-365
pubmed: 30702783
Am J Psychiatry. 2000 Jan;157(1):133-5
pubmed: 10618029
Chronobiol Int. 2017;34(7):845-854
pubmed: 28537802
J Affect Disord. 1988 May-Jun;14(3):257-64
pubmed: 2968387
Acta Psychiatr Scand. 2016 Nov;134(5):410-419
pubmed: 27553523
Neuron. 2019 Apr 3;102(1):128-142.e8
pubmed: 30795900
Can J Psychiatry. 2002 Oct;47(8):787-8
pubmed: 12420660
Biol Psychiatry. 2003 Sep 1;54(5):573-83
pubmed: 12946886
J Affect Disord. 1996 Oct 14;40(3):121-9
pubmed: 8897111
Bipolar Disord. 2019 Dec;21(8):741-773
pubmed: 31609530
Psychiatry Res. 2016 Aug 30;242:101-110
pubmed: 27267441
Proc Natl Acad Sci U S A. 2006 May 9;103(19):7414-9
pubmed: 16648247
Nat Rev Neurosci. 2014 Jul;15(7):443-54
pubmed: 24917305
Chronobiol Int. 2015;32(6):785-91
pubmed: 26134245
PLoS Biol. 2009 Jun 9;7(6):e1000125
pubmed: 19513122
J Nerv Ment Dis. 2012 Jan;200(1):51-5
pubmed: 22210362
J Neural Transm. 1988;72(2):147-65
pubmed: 3385426
Acta Psychiatr Scand Suppl. 2003;(418):92-5
pubmed: 12956822
J Affect Disord. 2014 Oct;168:210-23
pubmed: 25063960
Am Fam Physician. 2012 Dec 1;86(11):1037-41
pubmed: 23198671
Proc Natl Acad Sci U S A. 2016 Mar 15;113(11):E1536-44
pubmed: 26903630
Epidemiol Psychiatr Sci. 2017 Apr;26(2):169-176
pubmed: 26751782
Sleep Med Rev. 2019 Dec;48:101213
pubmed: 31600678
Neuroreport. 2015 Aug 19;26(12):675-80
pubmed: 26164454
J Appl Psychol. 1989 Oct;74(5):728-38
pubmed: 2793773
Acta Psychiatr Scand. 2000 Mar;101(3):176-84
pubmed: 10721866
Chronobiol Int. 2018 Sep;35(10):1335-1353
pubmed: 29939763
Dialogues Clin Neurosci. 2007;9(3):315-24
pubmed: 17969868
Sci Rep. 2019 Dec 2;9(1):18073
pubmed: 31792259
Behav Res Ther. 2012 Apr;50(4):231-9
pubmed: 22342167
J Affect Disord. 2004 Jun;80(2-3):209-19
pubmed: 15207934
Psychiatry Res. 2003 Aug 30;120(1):53-9
pubmed: 14500114
Nord J Psychiatry. 2004;58(6):429-37
pubmed: 16195086
Sleep Med Rev. 2012 Oct;16(5):445-54
pubmed: 22244990
Arch Gen Psychiatry. 1984 Jan;41(1):72-80
pubmed: 6581756
Sci Rep. 2015 May 19;5:10232
pubmed: 25989161
Eur J Pharmacol. 2015 Jul 15;759:151-62
pubmed: 25814263
Psychol Bull. 2017 Aug;143(8):783-822
pubmed: 28447828
Arch Gen Psychiatry. 1989 Sep;46(9):823-33
pubmed: 2789026
Neuropsychopharmacology. 2016 Sep;41(10):2447-54
pubmed: 27087270
Am J Psychiatry. 1995 Aug;152(8):1225-7
pubmed: 7625479
Lancet. 2002 Dec 7;360(9348):1840-2
pubmed: 12480364
Front Neurol. 2018 Dec 07;9:1047
pubmed: 30581410
Sleep Med. 2010 Feb;11(2):131-6
pubmed: 20044310
Gen Comp Endocrinol. 2018 Mar 1;258:244-249
pubmed: 28711512
Qual Life Res. 2021 Mar;30(3):647-673
pubmed: 33284428
Acta Psychiatr Scand Suppl. 2013;(444):24-30
pubmed: 23909694
Cell. 2002 May 3;109(3):307-20
pubmed: 12015981
J Affect Disord. 2016 Nov 15;205:81-86
pubmed: 27423064
Arch Gen Psychiatry. 1997 Feb;54(2):124-30
pubmed: 9040280
Biol Psychiatry. 1997 Nov 15;42(10):948-55
pubmed: 9359982
Sleep Med Rev. 2007 Dec;11(6):453-64
pubmed: 17936041
Psychiatry Res. 2003 Jan 25;117(1):75-83
pubmed: 12581822
Neuropsychopharmacology. 1989 Mar;2(1):1-22
pubmed: 2679625
Compr Psychiatry. 1993 May-Jun;34(3):159-70
pubmed: 8339533
Chronobiol Int. 2001 Sep;18(5):875-91
pubmed: 11763994